|Rice University, PhD|
Ashley Dombkowski joined 23andMe in July 2011 as Chief Business Officer with global responsibility for pharmaceutical and medical device partnerships. Prior to joining 23andMe, Ashley was managing director at MPM Capital, a healthcare-dedicated venture capital firm where she spent eleven years advancing the work of innovative, entrepreneurial healthcare companies. Previously she was a healthcare equity analyst for Tiger Management and Dresdner RCM Global Investors. Dr. Dombkowski holds a PhD in Mathematics from Rice University and received a BA in Mathematics from Wellesley College.